Microbial agents in cancer treatment.
Clark
J W
JW
Clinical Research Branch, National Cancer Institute, Frederick, Md.
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D009163:Mycobacterium bovis / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D000119:Acetylmuramyl-Alanyl-Isoglutamine